Quantcast

Industry news that matters to you.  Learn more

Johns Hopkins Medicine to Share Best Practices in the Apervita Health Analytics & Data Marketplace

Apervita, Inc., creators of the first real-time, cloud-based platform and marketplace for using and sharing health analytics & data, today announced Johns Hopkins Medicine has joined the rapidly growing number of leaders in health care research distributing algorithms proven to transform care delivery through the Apervita Market. For the first time, health enterprises everywhere will be able to access and deploy the extensive library of Johns Hopkins health innovations to improve patient outcomes.

Philips and Mount Sinai Health System Collaborate to Advance Clinical Research Through New Digital Pathology Database and Analytics

Royal Philips (NYSE:PHG, AEX:PHIA) recently announced a joint development agreement with the Mount Sinai Health System, an integrated health system in New York, to create a state-of-the-art digital image repository of patient tissue samples and innovative data analytics to pursue the discovery of new tissue-based tests and unlock pathology data. The collaboration aims to advance clinical research and ultimately enable better care for complex diseases, including cancer.

ConvergeHEALTH by Deloitte Announces Health System Intellect, a Comprehensive Analytics Solution Suite to Manage Margin, Cost and Quality

Recently at HIMSS14, ConvergeHEALTH by Deloitte announced the availability of Health System Intellect, an industry leading analytics solution that provides integrated views of clinical, operational and financial analytics to optimize reporting and performance at the process and key performance indicator level.

Thomson Reuters Reveals New Strategies for Navigating Big Data in the Pharmaceutical Industry

The IP & Science business of Thomson Reuters, the world’s leading provider of intelligent information for businesses and professionals, recently released Big Data and the Needs of the Pharma Industry, a whitepaper offering new strategies for managing Big Data, most specifically by using an array of technologies to convert it into more meaningful, accessible Little Data. The paper highlights how the inherently data-driven pharmaceutical industry requires deep, broad information to feed drug R&D, but the way it processes Big Data is unique.

Gentris Corporation Launches Next Generation Human Transcriptome Array

Gentris Corporation (www.gentris.com), a global leader in pharmacogenomics and biorepository solutions, recently announced that it is expanding its genomic biomarker offering with the launch of Affymetrix GeneChip(R) Human Transcriptome Array (HTA) services. The GeneChip(R) HTA is a high resolution microarray for gene expression that is designed to empower next-generation expression profiling studies. The new array goes beyond gene-level expression profiling by providing the coverage and accuracy required to detect all known transcript isoforms produced by a gene.